Sprouty 2 regulates DNA damage-induced apoptosis in Ras-transformed human fibroblasts

Area of Science:

• Cell Biology
• Molecular Oncology
• Signal Transduction

Background:

• Sprouty 2 (Spry2) is implicated in tumor formation in HRas(V12)-transformed fibroblasts.
• The role of Spry2 in regulating apoptosis following DNA damage requires further elucidation.

Purpose of the Study:

• To investigate the role of Spry2 in inhibiting UV radiation-induced apoptosis in HRas(V12)-transformed human fibroblasts.
• To determine the molecular mechanisms by which Spry2 regulates apoptosis, including its interaction with Akt, HDM2, p53, and Rac1.

Main Methods:

• Silencing Spry2 expression using RNA interference in HRas(V12)-transformed fibroblasts.
• Overexpression of Spry2 in non-transformed parental fibroblasts.
• UV irradiation and cisplatin treatment to induce DNA damage and apoptosis.
• Western blotting to assess protein levels and activation states (Akt, HDM2, p53).
• Rac1 activation assays and assessment of HRas-Tiam1 interaction.
• Rescue experiments using constitutively active Rac1.

Main Results:

• Silencing Spry2 in HRas(V12)-transformed cells increased UV-induced apoptosis, decreased Akt activation, and reduced HDM2 phosphorylation, leading to elevated p53 levels.
• Overexpression of Spry2 in non-transformed cells decreased UV-induced apoptosis, increased Akt activation, stabilized HDM2, and reduced p53 levels.
• Spry2 silencing decreased Rac1 activation in HRas-transformed cells and diminished HRas-Tiam1 interaction, suggesting a role in Ras-mediated Rac1 activation.
• Loss of Spry2 expression augmented cisplatin-induced cytotoxicity, which was reversed by active Rac1.

Conclusions:

• Spry2 acts as an inhibitor of apoptosis in response to DNA damage in HRas-transformed cells.
• Spry2 regulates apoptosis by modulating the Akt-HDM2-p53 signaling axis.
• Rac1 activation is a key mediator in Spry2's anti-apoptotic function, particularly in the context of Ras transformation.